应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IFRX InflaRx N.V.
休市中 05-24 16:00:00 EDT
1.44
-0.04
-2.70%
盘后
1.44
+0.00
0.00%
17:32 EDT
最高
1.51
最低
1.43
成交量
20.98万
今开
1.49
昨收
1.48
日振幅
5.41%
总市值
8,479万
流通市值
7,030万
总股本
5,888万
成交额
30.79万
换手率
0.43%
流通股本
4,882万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Inflarx N.V.盘中异动 急速下挫5.02%报1.23美元
自选股智能写手 · 05-08
Inflarx N.V.盘中异动 急速下挫5.02%报1.23美元
Inflarx N.V.盘中异动 股价大跌5.07%报1.31美元
自选股智能写手 · 05-06
Inflarx N.V.盘中异动 股价大跌5.07%报1.31美元
Inflarx N.V.盘中异动 急速跳水5.04%
自选股智能写手 · 04-27
Inflarx N.V.盘中异动 急速跳水5.04%
Inflarx N.V.盘中异动 快速拉升5.95%报1.34美元
自选股智能写手 · 04-19
Inflarx N.V.盘中异动 快速拉升5.95%报1.34美元
Inflarx N.V.盘中异动 早盘快速拉升5.14%
自选股智能写手 · 04-18
Inflarx N.V.盘中异动 早盘快速拉升5.14%
Inflarx N.V.盘中异动 早盘大幅拉升8.55%报1.65美元
自选股智能写手 · 04-11
Inflarx N.V.盘中异动 早盘大幅拉升8.55%报1.65美元
加载更多
公司概况
公司名称:
InflaRx N.V.
所属市场:
NASDAQ
上市日期:
--
主营业务:
InflaRx N.V.于2017年6月根据荷兰法律成立,根据公司重组的条款,该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司,专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质,涉及多种自身免疫和其他炎症疾病的进展。
发行价格:
--
{"stockData":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.44,"timestamp":1716580800000,"preClose":1.48,"halted":0,"volume":209753,"hourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"17:32 EDT","volume":35,"amount":49.7,"timestamp":1716586345450},"delay":0,"floatShares":48818407,"shares":58883272,"eps":-0.766359,"marketStatus":"休市中","marketStatusCode":7,"change":-0.04,"latestTime":"05-24 16:00:00 EDT","open":1.49,"high":1.51,"low":1.43,"amount":307906.496844,"amplitude":0.054054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.766359,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716883200000},"adr":0,"listingDate":1510117200000,"adjPreClose":1.48,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.48,"preClose":1.48,"latestTime":"09:28 EDT","volume":13,"amount":19.2304,"timestamp":1716557321355},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"17:32 EDT","volume":35,"amount":49.7,"timestamp":1716586345450},"volumeRatio":0.6794025015020201},"requestUrl":"/m/hq/s/IFRX/","defaultTab":"news","newsList":[{"id":"2433731899","title":"Inflarx N.V.盘中异动 急速下挫5.02%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433731899","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433731899?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:30","pubTimestamp":1715110233,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日03时30分,Inflarx N.V.股票出现异动,股价大幅跳水5.02%。截至发稿,该股报1.23美元/股,成交量10.5298万股,换手率0.18%,振幅6.18%。Inflarx N.V.股票所在的生物技术行业中,整体涨幅为1.20%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080330347a5889df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080330347a5889df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433470010","title":"Inflarx N.V.盘中异动 股价大跌5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433470010","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433470010?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:49","pubTimestamp":1715006965,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时49分,Inflarx N.V.股票出现异动,股价急速跳水5.07%。截至发稿,该股报1.31美元/股,成交量4.1009万股,换手率0.07%,振幅6.52%。Inflarx N.V.股票所在的生物技术行业中,整体跌幅为0.15%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506224925861eb35e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506224925861eb35e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430821727","title":"Inflarx N.V.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430821727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430821727?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:09","pubTimestamp":1714154995,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日02时09分,Inflarx N.V.股票出现波动,股价大幅下挫5.04%。截至发稿,该股报1.32美元/股,成交量5.1872万股,换手率0.09%,振幅7.12%。Inflarx N.V.股票所在的生物技术行业中,整体涨幅为0.47%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428507836","title":"Inflarx N.V.盘中异动 快速拉升5.95%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428507836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428507836?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:23","pubTimestamp":1713536587,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时23分,Inflarx N.V.股票出现异动,股价大幅拉升5.95%。截至发稿,该股报1.34美元/股,成交量4.0276万股,换手率0.07%,振幅3.97%。Inflarx N.V.股票所在的生物技术行业中,整体涨幅为0.56%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041922230887e8225d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041922230887e8225d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428959787","title":"Inflarx N.V.盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428959787","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428959787?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:45","pubTimestamp":1713447943,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时45分,Inflarx N.V.股票出现波动,股价快速拉升5.14%。截至发稿,该股报1.33美元/股,成交量2.9179万股,换手率0.05%,振幅6.32%。Inflarx N.V.股票所在的生物技术行业中,整体跌幅为0.73%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182145437a53cab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182145437a53cab3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426686572","title":"Inflarx N.V.盘中异动 早盘大幅拉升8.55%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426686572","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426686572?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:35","pubTimestamp":1712842502,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时35分,Inflarx N.V.股票出现波动,股价大幅上涨8.55%。截至发稿,该股报1.65美元/股,成交量6363股,换手率0.01%,振幅3.29%。Inflarx N.V.股票所在的生物技术行业中,整体涨幅为0.00%。Inflarx N.V.公司简介:InflaRx NV是一家临床生物制药公司,致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV,这是一种威胁生命的自身免疫性疾病,与严重的炎症发作相关,会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112135028b1092da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112135028b1092da&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inflarx.com","stockEarnings":[{"period":"1week","weight":-0.1166},{"period":"1month","weight":0.0588},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0069},{"period":"1year","weight":-0.6488},{"period":"ytd","weight":-0.1166}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InflaRx N.V.于2017年6月根据荷兰法律成立,根据公司重组的条款,该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司,专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质,涉及多种自身免疫和其他炎症疾病的进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.090583},{"month":2,"riseRate":0.571429,"avgChangeRate":0.006427},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.068353},{"month":4,"riseRate":0.571429,"avgChangeRate":0.389384},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.048926},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.26601},{"month":7,"riseRate":0.333333,"avgChangeRate":0.114861},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.053477},{"month":9,"riseRate":0.5,"avgChangeRate":-0.032601},{"month":10,"riseRate":0.333333,"avgChangeRate":0.016141},{"month":11,"riseRate":0.5,"avgChangeRate":0.042008},{"month":12,"riseRate":0.714286,"avgChangeRate":0.137243}],"exchange":"NASDAQ","name":"InflaRx N.V.","nameEN":"InflaRx N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InflaRx N.V.,IFRX,InflaRx N.V.股票,InflaRx N.V.股票老虎,InflaRx N.V.股票老虎国际,InflaRx N.V.行情,InflaRx N.V.股票行情,InflaRx N.V.股价,InflaRx N.V.股市,InflaRx N.V.股票价格,InflaRx N.V.股票交易,InflaRx N.V.股票购买,InflaRx N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}